Potassium-sparing diuretics or antikaliuretics refer to drugs that cause
diuresis
Diuresis () is the excretion of urine, especially when excessive (polyuria). The term collectively denotes the physiologic processes underpinning increased urine production by the kidneys during maintenance of fluid balance.
In healthy people, ...
without causing
potassium
Potassium is a chemical element; it has Symbol (chemistry), symbol K (from Neo-Latin ) and atomic number19. It is a silvery white metal that is soft enough to easily cut with a knife. Potassium metal reacts rapidly with atmospheric oxygen to ...
loss in the
urine
Urine is a liquid by-product of metabolism in humans and many other animals. In placental mammals, urine flows from the Kidney (vertebrates), kidneys through the ureters to the urinary bladder and exits the urethra through the penile meatus (mal ...
.
They are typically used as an
adjunct in management of
hypertension
Hypertension, also known as high blood pressure, is a Chronic condition, long-term Disease, medical condition in which the blood pressure in the artery, arteries is persistently elevated. High blood pressure usually does not cause symptoms i ...
,
cirrhosis
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, chronic liver failure or chronic hepatic failure and end-stage liver disease, is a chronic condition of the liver in which the normal functioning tissue, or parenchyma, is replaced ...
, and
congestive heart failure
Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.
Although symptoms vary based on which side of the heart is affected, HF typically pr ...
. The steroidal
aldosterone antagonists can also be used for treatment of
primary hyperaldosteronism.
Spironolactone
Spironolactone, sold under the brand name Aldactone among others, is classed as a diuretic medication. It can be used to treat edema, fluid build-up due to hepatic cirrhosis, liver disease or kidney disease. It is also used to reduce risk o ...
, a
steroidal aldosterone antagonist, is also used in management of female
hirsutism
Hirsutism is excessive body hair on parts of the body where hair is normally absent or minimal. The word is from early 17th century: from Latin ''hirsutus'' meaning "hairy". It usually refers to a male pattern of hair growth in a female that ma ...
and
acne
Acne ( ), also known as ''acne vulgaris'', is a long-term Cutaneous condition, skin condition that occurs when Keratinocyte, dead skin cells and Sebum, oil from the skin clog hair follicles. Typical features of the condition include comedo, ...
from
PCOS
Polycystic ovary syndrome, or polycystic ovarian syndrome, (PCOS) is the most common endocrine disorder in women of reproductive age. The name is a misnomer, as not all women with this condition develop cysts on their ovaries. The name origi ...
or
other causes.
Types of potassium-sparing diuretics
*
Epithelial sodium channel blockers:
**
Amiloride better tolerated than triamterene
**
Triamterene increased renal side-effects
*
Aldosterone antagonists, also known as
mineralocorticoid receptor antagonists:
**
Spironolactone
Spironolactone, sold under the brand name Aldactone among others, is classed as a diuretic medication. It can be used to treat edema, fluid build-up due to hepatic cirrhosis, liver disease or kidney disease. It is also used to reduce risk o ...
most widespread use, inexpensive
**
Eplerenone more selective so reduced side-effects but more expensive and less potent
**
Finerenone non-steroidal, more selective and potent than spironolactone and eplerenone
**
Canrenone very limited use
Mechanism of action
Normally, sodium is reabsorbed in the
collecting tubules of a renal
nephron
The nephron is the minute or microscopic structural and functional unit of the kidney. It is composed of a renal corpuscle and a renal tubule. The renal corpuscle consists of a tuft of capillaries called a glomerulus and a cup-shaped structu ...
. This occurs via epithelial sodium channels or ENaCs, located on the luminal surface of principal cells that line the collecting tubules. Positively-charged Na+ entering the cells during reabsorption leads to an electronegative luminal environment causing the secretion of potassium (K
+) into the lumen/ urine in exchange.
Sodium reabsorption also causes water retention.
When the kidneys detect low blood pressure, the
renin–angiotensin–aldosterone system (RAAS) is activated and eventually, aldosterone is secreted. Aldosterone binds to aldosterone receptors (mineralocorticoid receptors) increasing sodium reabsorption in an effort to increase blood pressure and improve fluid status in the body. When excessive sodium reabsorption occurs, there is an increasing loss of K
+ in the urine and can lead to clinically significant decreases, termed
hypokalemia
Hypokalemia is a low level of potassium (K+) in the blood serum. Mild low potassium does not typically cause symptoms. Symptoms may include feeling tired, leg cramps, weakness, and constipation. Low potassium also increases the risk of an a ...
. Increased sodium reabsorption also increases water retention.
Potassium-sparing diuretics act to prevent sodium reabsorption in the collecting tubule by either binding ENaCs (amiloride, triamterene) or by inhibiting aldosterone receptors (spironolactone, eplerenone). This prevents excessive excretion of K
+ in urine and decreased retention of water, preventing hypokalemia.
Because these diuretics are weakly
natriuretic, they do not cause clinically significant blood pressure changes and thus, are not used as primary therapy for hypertension.
They can be used in combination with other
anti-hypertensives or drugs that cause hypokalemia to help maintain a
normal range for potassium. For example, they are often used as an adjunct to
loop diuretics (usually
furosemide
Furosemide, sold under the brand name Lasix among others, is a loop diuretic medication used to treat edema due to heart failure, liver scarring, or kidney disease. Furosemide may also be used for the treatment of high blood pressure. It can ...
) to treat fluid retention in
congestive heart failure
Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.
Although symptoms vary based on which side of the heart is affected, HF typically pr ...
and
ascites
Ascites (; , meaning "bag" or "sac") is the abnormal build-up of fluid in the abdomen. Technically, it is more than 25 ml of fluid in the peritoneal cavity, although volumes greater than one liter may occur. Symptoms may include increased abdo ...
in
cirrhosis
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, chronic liver failure or chronic hepatic failure and end-stage liver disease, is a chronic condition of the liver in which the normal functioning tissue, or parenchyma, is replaced ...
.
Adverse effects
On their own this group of drugs may raise potassium levels beyond the normal range, termed
hyperkalemia
Hyperkalemia is an elevated level of potassium (K+) in the blood. Normal potassium levels are between 3.5 and 5.0 mmol/L (3.5 and 5.0 mEq/L) with levels above 5.5mmol/L defined as hyperkalemia. Typically hyperkalemia does not cause symptoms. Oc ...
, which risks potentially fatal
arrhythmia
Arrhythmias, also known as cardiac arrhythmias, are irregularities in the cardiac cycle, heartbeat, including when it is too fast or too slow. Essentially, this is anything but normal sinus rhythm. A resting heart rate that is too fast – ab ...
s. Triamterene, specifically, is a potential nephrotoxin and up to half of the patients on it can have
crystalluria or
urinary casts.
Due to its activity as an androgen receptor antagonist and progesterone receptor agonist, spironolactone causes adverse effects, including gynecomastia or decreased libido in males and menstrual abnormalities in females.
Spironolactone also causes hyperkalemia
and renal insufficiency.
Drug Interactions
Spironolactone interacts with the following medications:
- ACE inhibitors/ARBs: increases hyperkalemia risk
- Alcohol: risk of orthostatic hypotension
- Barbiturates: risk of orthostatic hypotension
- Narcotics: risk of orthostatic hypotension
- NSAIDs: increases hyperkalemia risk and decreases diuretic effect of potassium-sparing diuretics
- Digoxin: increases digoxin plasma concentrations, leading to increased toxicity
See also
*
C03D Potassium-sparing agents
*
Kaliuresis
References
External links
*
{{Portal bar , Medicine
Potassium-sparing diuretics
Cardiology